Search Results 211-220 of 11381 for ���������������������������:za33���24������ ������������������������ ������

  1. Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery - Mayo Clinic

    ... 24-hour urine total protein must be obtained; subjects must have a 24-hour urine protein value < 1 g to be eligible; use of urine dipstick for renal function

  2. Epilepsy surgery - Mayo Clinic

    Seizures and epilepsy. In: Harrison's Principles of Internal Medicine. 21st ed. McGraw Hill; 2022. https://accessmedicine.mhmedical.com. Accessed June 24, 2024.

  3. New breast cancer drug study results are promising

    00:00 / 00:00. Share · Tweet . VID-20381066. Home; New breast cancer drug study results are promising. Fuel groundbreaking medical research!

  4. Clinical Trials - FT576 in Subjects With Multiple Myeloma

    ... 24 hours - Regimens A and A1: MM relapsed or progressed after ≥ 3 prior approved therapies, including an IMiD, proteosome inhibitor, and anti-CD38 mAb

  5. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-007969; Jacksonville, Florida: 24-007969. NCT ID: NCT05868226. Sponsor Protocol Number: I-SPY-P1. About this study. The ...

  6. Birth control patch - Mayo Clinic

    If your patch becomes partially or completely detached for more than 24 hours, apply a new patch and use a backup method of contraception for one week. Skip ...

  7. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

    ... 24 hours[hrs]); OR - IgA, IgM, IgD, or IgE multiple myeloma (serum M-protein level >= 0.2 g/dL or urine M-protein level >= 200 mg/24 hrs); OR - Light chain ...

  8. Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs (TRACY-1) - Mayo Clinic

    Jacksonville, Florida: 24-010409; Scottsdale/Phoenix, Arizona: 24-010409. NCT ID: NCT06590857. Sponsor Protocol Number: RYZ101-201. About this study. The ...

  9. A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/​or Refractory Multiple Myeloma - Mayo Clinic

    Jacksonville, Florida: 24-004039; Scottsdale/Phoenix, Arizona: 24-004039. NCT ID: NCT06121843. Sponsor Protocol Number: CA0881005. About this study. The ...

  10. A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas - Mayo Clinic

    Participation eligibility · Subject who has a life expectancy of less than 24 months. · Subjects who are cognitively impaired and have a healthcare proxy or those ...